Barentz, a global leading distributor of life science ingredients, has opened a new, cutting-edge pharmaceutical development centre.
According to Barentz: “The new centre, located in the heart of Mexico City, is designed to foster collaboration, inspire creativity, and drive formulation excellence to produce the most effective treatments for those who matter most: the patients. Additionally, our facility is fully equipped to offer technical support and training to our customers and suppliers.”
Julio Rendon, Mexico Managing Director said. “With the opening of this facility, Barentz is showing its commitment to the pharmaceutical and nutritional markets in not only Mexico but the broader North American region. This will help reduce the time it takes for customers to develop and launch new products. Barentz’ investment demonstrates our dedication to providing top-notch products and services.”
Mike McKenna, Barentz’s North American CEO, said: “The inauguration of this site is a testament to Barentz’ commitment to become a global market leader in the pharmaceutical segment. We are incredibly excited to invest in our commercial and technical teams who collaborate with our Principal partners to deliver value for the benefit of our customers every day.
The new facility will focus on a range of key formulation areas, including formulation development and analytical characterisation for both oral solids and liquid dosage forms. The team of experts will work collaboratively to meet the evolving needs of the pharmaceutical industry.